RxDoctor Payments Data

Rawan Maali, MD

Family Medicine · Santa Fe, NMNPI 1447645429

Payments from drug & device makers

$1,981in general payments, 2019–2025

Across 56 payments — averaging $35.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Revance Therapeutics, Inc.$905
  • AbbVie$854
  • Merz North America, Inc.$155
  • Biowound Solutions, Inc.$29
  • Philips North America LLC$24
  • Galderma Laboratories, L.p.$14

What the payments were for

  • Food & beverage$1,93097%
  • Education$513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Revance Therapeutics, Inc.21$905
AbbVie(2 entities)28$854
Merz North America, Inc.4$155
Biowound Solutions, Inc.1$29
Philips North America LLC1$24
Galderma Laboratories, L.p.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,981 in reported general payments places this provider in the 85th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$12,634
Medicare patients
50
Services billed
128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Chloride15$214

Paid to pharmacies, not to this prescriber.

Other family medicine in Santa Fe

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →